EP1361866A4 - Emulsions en formes posologiques solides pour l'administration orale - Google Patents

Emulsions en formes posologiques solides pour l'administration orale

Info

Publication number
EP1361866A4
EP1361866A4 EP20010913012 EP01913012A EP1361866A4 EP 1361866 A4 EP1361866 A4 EP 1361866A4 EP 20010913012 EP20010913012 EP 20010913012 EP 01913012 A EP01913012 A EP 01913012A EP 1361866 A4 EP1361866 A4 EP 1361866A4
Authority
EP
European Patent Office
Prior art keywords
emulsions
dosage forms
oral administration
solid dosage
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP20010913012
Other languages
German (de)
English (en)
Other versions
EP1361866A1 (fr
Inventor
S Indiran Pather
Sangeeta V Gupte
Rajendra K Khankari
Jon Hontz
Ramya Kumbale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cima Labs Inc
Original Assignee
Cima Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cima Labs Inc filed Critical Cima Labs Inc
Publication of EP1361866A1 publication Critical patent/EP1361866A1/fr
Publication of EP1361866A4 publication Critical patent/EP1361866A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
EP20010913012 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale Ceased EP1361866A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/005978 WO2002083102A1 (fr) 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale

Publications (2)

Publication Number Publication Date
EP1361866A1 EP1361866A1 (fr) 2003-11-19
EP1361866A4 true EP1361866A4 (fr) 2007-10-17

Family

ID=21742362

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20010913012 Ceased EP1361866A4 (fr) 2001-02-23 2001-02-23 Emulsions en formes posologiques solides pour l'administration orale

Country Status (5)

Country Link
EP (1) EP1361866A4 (fr)
JP (1) JP5684440B2 (fr)
AU (1) AU2001241730B2 (fr)
CA (1) CA2437762C (fr)
WO (1) WO2002083102A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2851918B1 (fr) * 2003-03-06 2006-06-16 Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication
MX340669B (es) * 2008-09-09 2016-07-20 Cima Labs Inc Formas farmaceuticas para compuestos debilmente ionizables.
US20120213855A1 (en) * 2011-02-17 2012-08-23 Cima Labs Inc. Dosage forms for weakly ionizable compounds
ES2395801B1 (es) * 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468815A (en) * 1973-10-18 1977-03-30 Vymatt Sa Pharmaceutical compositions
WO1997047290A1 (fr) * 1996-06-10 1997-12-18 Spiridon Spireas Systemes liquisolides et leurs procedes de production
WO2000009093A1 (fr) * 1998-08-13 2000-02-24 Cima Labs Inc. Microemulsions comme formes pharmaceutiques solides destinees a une administration orale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586568A5 (fr) * 1972-04-10 1977-04-15 Hoffmann La Roche
JPS58213073A (ja) * 1982-06-07 1983-12-10 Masatoshi Yamada 油状物質の固形化法
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
JP4027535B2 (ja) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 脂溶性薬物を含有した粉末
JP2000016934A (ja) * 1998-06-30 2000-01-18 Eisai Co Ltd テプレノンを含有した錠剤
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468815A (en) * 1973-10-18 1977-03-30 Vymatt Sa Pharmaceutical compositions
WO1997047290A1 (fr) * 1996-06-10 1997-12-18 Spiridon Spireas Systemes liquisolides et leurs procedes de production
WO2000009093A1 (fr) * 1998-08-13 2000-02-24 Cima Labs Inc. Microemulsions comme formes pharmaceutiques solides destinees a une administration orale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02083102A1 *

Also Published As

Publication number Publication date
JP5684440B2 (ja) 2015-03-11
AU2001241730B2 (en) 2007-03-15
JP2004524370A (ja) 2004-08-12
EP1361866A1 (fr) 2003-11-19
WO2002083102A1 (fr) 2002-10-24
CA2437762C (fr) 2010-08-10
CA2437762A1 (fr) 2002-10-24

Similar Documents

Publication Publication Date Title
PL356358A1 (en) Solid dosage form of someticone for oral administration
GB0117618D0 (en) Pharmaceutical dosage form
PL367180A1 (en) Stabilized oral pharmaceutical composition
EG23943A (en) Flash-melt oral dosage formulation
MXPA03006476A (es) Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
EP1372392A4 (fr) Forme posologique orale contenant de la nicotine
AU2002301259A1 (en) Simethicone solid oral dosage form
IL166286A0 (en) Multicomponent pharmaceutical dosage form
GB0117619D0 (en) Pharmaceutical dosage form
HUP0400850A3 (en) Oral pharmaceutical compositions
HUP0500638A3 (en) Flashmelt oral dosage formulation
GB0101225D0 (en) Pharmaceutical compounds
GB0101227D0 (en) Pharmaceutical compounds
HK1092715A1 (en) Melt-formulated, multi-particulate oral dosage form
HK1089959A1 (en) Saquinavir mesylate oral dosage form
IL162510A0 (en) Pharmaceutical suspension for oral administration
EP1361866A4 (fr) Emulsions en formes posologiques solides pour l'administration orale
HUP0401599A3 (en) Extended release oral dosage form
EP1357898A4 (fr) Forme posologique orale a liberation regulee amelioree
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents
PL373799A1 (en) Flashmelt oral dosage formulation
PL341178A1 (en) Oral pharmaceutical dosage forms
AU2002301781A1 (en) Solid pharmaceutical compositions for oral administration comprising itraconazole
GB0124010D0 (en) Pharmaceutical compositions for inhalation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030821

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20070918

17Q First examination report despatched

Effective date: 20090423

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20151022